Skip to main content
Premium Trial:

Request an Annual Quote

BioMicro Systems, Infineon, Axon Instruments

Premium

BioMicro Systems of Salt Lake City, Utah, last week introduced a semi-automated MAUI hybridization system. The company said it improves sensitivity for low-abundance genes over traditional methods of hybridization for microarray analysis. The new system allows users to simultaneously process up to four standard microarrays with controlled heating and mixing.

 

Infineon of Munich, Germany, will introduce its Flow-Thru Chip system this week. The system, which includes biochips and instruments, sells for €60,000 ($63,000) and is available in kits for inflammation, cancer (lung and breast), and neurological diseases such as Alzheimer’s, Parkinson’s and MS. The system includes biochips, a hybridization unit, and a CCD camera and system for data collection.

 

Axon Instruments is introducing the 4200A, a fully configurable four-color scanner (see page 3).

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.